COVID-19 Impact on Global Oncology Injection Drug, Market Insights and Forecast to 2026
Oncology Injection Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oncology Injection Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Oncology Injection Drug market is segmented into
The Oncology Injection Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Oncology Injection Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oncology Injection Drug Market Share Analysis
Oncology Injection Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oncology Injection Drug business, the date to enter into the Oncology Injection Drug market, Oncology Injection Drug product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Oncology Injection Drug market is segmented into
- Organs
- Central Nervous System
- Circulatory/Musculoskeletal System
- Other
- Lymphoma
- Myeloma
- Prostate Cancer
- Other
The Oncology Injection Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Oncology Injection Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oncology Injection Drug Market Share Analysis
Oncology Injection Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oncology Injection Drug business, the date to enter into the Oncology Injection Drug market, Oncology Injection Drug product introduction, recent developments, etc.
The major vendors covered:
- Taj Oncology
- S.G. Biopharm
- AdvaCare
- Merrimack
- Celgene
- Allos Therapeutics
- Ferring Pharmaceuticals
- Genzyme
- Eli Lilly
- Praecis Pharmaceuticals
- Millennium Pharmaceuticals
- Debiopharm
- Alza
- CordenPharma
- Pharmascience
1 STUDY COVERAGE
1.1 Oncology Injection Drug Product Introduction
1.2 Market Segments
1.3 Key Oncology Injection Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Oncology Injection Drug Market Size Growth Rate by Type
1.4.2 Organs
1.4.3 Central Nervous System
1.4.4 Circulatory/Musculoskeletal System
1.4.5 Other
1.5 Market by Application
1.5.1 Global Oncology Injection Drug Market Size Growth Rate by Application
1.5.2 Lymphoma
1.5.3 Myeloma
1.5.4 Prostate Cancer
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Oncology Injection Drug Industry Impact
1.6.1 How the Covid-19 is Affecting the Oncology Injection Drug Industry
1.6.1.1 Oncology Injection Drug Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Oncology Injection Drug Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Oncology Injection Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Oncology Injection Drug Market Size Estimates and Forecasts
2.1.1 Global Oncology Injection Drug Revenue 2015-2026
2.1.2 Global Oncology Injection Drug Sales 2015-2026
2.2 Oncology Injection Drug Market Size by Region: 2020 Versus 2026
2.2.1 Global Oncology Injection Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Oncology Injection Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL ONCOLOGY INJECTION DRUG COMPETITOR LANDSCAPE BY PLAYERS
3.1 Oncology Injection Drug Sales by Manufacturers
3.1.1 Oncology Injection Drug Sales by Manufacturers (2015-2020)
3.1.2 Oncology Injection Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Oncology Injection Drug Revenue by Manufacturers
3.2.1 Oncology Injection Drug Revenue by Manufacturers (2015-2020)
3.2.2 Oncology Injection Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Oncology Injection Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Oncology Injection Drug Revenue in 2019
3.2.5 Global Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Oncology Injection Drug Price by Manufacturers
3.4 Oncology Injection Drug Manufacturing Base Distribution, Product Types
3.4.1 Oncology Injection Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oncology Injection Drug Product Type
3.4.3 Date of International Manufacturers Enter into Oncology Injection Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Oncology Injection Drug Market Size by Type (2015-2020)
4.1.1 Global Oncology Injection Drug Sales by Type (2015-2020)
4.1.2 Global Oncology Injection Drug Revenue by Type (2015-2020)
4.1.3 Oncology Injection Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Oncology Injection Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Oncology Injection Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Oncology Injection Drug Revenue Forecast by Type (2021-2026)
4.2.3 Oncology Injection Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Oncology Injection Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Oncology Injection Drug Market Size by Application (2015-2020)
5.1.1 Global Oncology Injection Drug Sales by Application (2015-2020)
5.1.2 Global Oncology Injection Drug Revenue by Application (2015-2020)
5.1.3 Oncology Injection Drug Price by Application (2015-2020)
5.2 Oncology Injection Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Oncology Injection Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Oncology Injection Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Oncology Injection Drug Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Oncology Injection Drug by Country
6.1.1 North America Oncology Injection Drug Sales by Country
6.1.2 North America Oncology Injection Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Oncology Injection Drug Market Facts & Figures by Type
6.3 North America Oncology Injection Drug Market Facts & Figures by Application
7 EUROPE
7.1 Europe Oncology Injection Drug by Country
7.1.1 Europe Oncology Injection Drug Sales by Country
7.1.2 Europe Oncology Injection Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oncology Injection Drug Market Facts & Figures by Type
7.3 Europe Oncology Injection Drug Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Oncology Injection Drug by Region
8.1.1 Asia Pacific Oncology Injection Drug Sales by Region
8.1.2 Asia Pacific Oncology Injection Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Oncology Injection Drug Market Facts & Figures by Type
8.3 Asia Pacific Oncology Injection Drug Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Oncology Injection Drug by Country
9.1.1 Latin America Oncology Injection Drug Sales by Country
9.1.2 Latin America Oncology Injection Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Oncology Injection Drug Market Facts & Figures by Type
9.3 Central & South America Oncology Injection Drug Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Oncology Injection Drug by Country
10.1.1 Middle East and Africa Oncology Injection Drug Sales by Country
10.1.2 Middle East and Africa Oncology Injection Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Oncology Injection Drug Market Facts & Figures by Type
10.3 Middle East and Africa Oncology Injection Drug Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Taj Oncology
11.1.1 Taj Oncology Corporation Information
11.1.2 Taj Oncology Description, Business Overview and Total Revenue
11.1.3 Taj Oncology Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Taj Oncology Oncology Injection Drug Products Offered
11.1.5 Taj Oncology Recent Development
11.2 S.G. Biopharm
11.2.1 S.G. Biopharm Corporation Information
11.2.2 S.G. Biopharm Description, Business Overview and Total Revenue
11.2.3 S.G. Biopharm Sales, Revenue and Gross Margin (2015-2020)
11.2.4 S.G. Biopharm Oncology Injection Drug Products Offered
11.2.5 S.G. Biopharm Recent Development
11.3 AdvaCare
11.3.1 AdvaCare Corporation Information
11.3.2 AdvaCare Description, Business Overview and Total Revenue
11.3.3 AdvaCare Sales, Revenue and Gross Margin (2015-2020)
11.3.4 AdvaCare Oncology Injection Drug Products Offered
11.3.5 AdvaCare Recent Development
11.4 Merrimack
11.4.1 Merrimack Corporation Information
11.4.2 Merrimack Description, Business Overview and Total Revenue
11.4.3 Merrimack Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merrimack Oncology Injection Drug Products Offered
11.4.5 Merrimack Recent Development
11.5 Celgene
11.5.1 Celgene Corporation Information
11.5.2 Celgene Description, Business Overview and Total Revenue
11.5.3 Celgene Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Celgene Oncology Injection Drug Products Offered
11.5.5 Celgene Recent Development
11.6 Allos Therapeutics
11.6.1 Allos Therapeutics Corporation Information
11.6.2 Allos Therapeutics Description, Business Overview and Total Revenue
11.6.3 Allos Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Allos Therapeutics Oncology Injection Drug Products Offered
11.6.5 Allos Therapeutics Recent Development
11.7 Ferring Pharmaceuticals
11.7.1 Ferring Pharmaceuticals Corporation Information
11.7.2 Ferring Pharmaceuticals Description, Business Overview and Total Revenue
11.7.3 Ferring Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Ferring Pharmaceuticals Oncology Injection Drug Products Offered
11.7.5 Ferring Pharmaceuticals Recent Development
11.8 Genzyme
11.8.1 Genzyme Corporation Information
11.8.2 Genzyme Description, Business Overview and Total Revenue
11.8.3 Genzyme Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Genzyme Oncology Injection Drug Products Offered
11.8.5 Genzyme Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Corporation Information
11.9.2 Eli Lilly Description, Business Overview and Total Revenue
11.9.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Eli Lilly Oncology Injection Drug Products Offered
11.9.5 Eli Lilly Recent Development
11.10 Praecis Pharmaceuticals
11.10.1 Praecis Pharmaceuticals Corporation Information
11.10.2 Praecis Pharmaceuticals Description, Business Overview and Total Revenue
11.10.3 Praecis Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Praecis Pharmaceuticals Oncology Injection Drug Products Offered
11.10.5 Praecis Pharmaceuticals Recent Development
11.1 Taj Oncology
11.1.1 Taj Oncology Corporation Information
11.1.2 Taj Oncology Description, Business Overview and Total Revenue
11.1.3 Taj Oncology Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Taj Oncology Oncology Injection Drug Products Offered
11.1.5 Taj Oncology Recent Development
11.12 Debiopharm
11.12.1 Debiopharm Corporation Information
11.12.2 Debiopharm Description, Business Overview and Total Revenue
11.12.3 Debiopharm Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Debiopharm Products Offered
11.12.5 Debiopharm Recent Development
11.13 Alza
11.13.1 Alza Corporation Information
11.13.2 Alza Description, Business Overview and Total Revenue
11.13.3 Alza Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Alza Products Offered
11.13.5 Alza Recent Development
11.14 CordenPharma
11.14.1 CordenPharma Corporation Information
11.14.2 CordenPharma Description, Business Overview and Total Revenue
11.14.3 CordenPharma Sales, Revenue and Gross Margin (2015-2020)
11.14.4 CordenPharma Products Offered
11.14.5 CordenPharma Recent Development
11.15 Pharmascience
11.15.1 Pharmascience Corporation Information
11.15.2 Pharmascience Description, Business Overview and Total Revenue
11.15.3 Pharmascience Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Pharmascience Products Offered
11.15.5 Pharmascience Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Oncology Injection Drug Market Estimates and Projections by Region
12.1.1 Global Oncology Injection Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Oncology Injection Drug Revenue Forecast by Regions 2021-2026
12.2 North America Oncology Injection Drug Market Size Forecast (2021-2026)
12.2.1 North America: Oncology Injection Drug Sales Forecast (2021-2026)
12.2.2 North America: Oncology Injection Drug Revenue Forecast (2021-2026)
12.2.3 North America: Oncology Injection Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Oncology Injection Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Oncology Injection Drug Sales Forecast (2021-2026)
12.3.2 Europe: Oncology Injection Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Oncology Injection Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Oncology Injection Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Oncology Injection Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Oncology Injection Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Oncology Injection Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Oncology Injection Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Oncology Injection Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Oncology Injection Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Oncology Injection Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Oncology Injection Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Oncology Injection Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Oncology Injection Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Oncology Injection Drug Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Oncology Injection Drug Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Oncology Injection Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Oncology Injection Drug Product Introduction
1.2 Market Segments
1.3 Key Oncology Injection Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Oncology Injection Drug Market Size Growth Rate by Type
1.4.2 Organs
1.4.3 Central Nervous System
1.4.4 Circulatory/Musculoskeletal System
1.4.5 Other
1.5 Market by Application
1.5.1 Global Oncology Injection Drug Market Size Growth Rate by Application
1.5.2 Lymphoma
1.5.3 Myeloma
1.5.4 Prostate Cancer
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Oncology Injection Drug Industry Impact
1.6.1 How the Covid-19 is Affecting the Oncology Injection Drug Industry
1.6.1.1 Oncology Injection Drug Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Oncology Injection Drug Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Oncology Injection Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Oncology Injection Drug Market Size Estimates and Forecasts
2.1.1 Global Oncology Injection Drug Revenue 2015-2026
2.1.2 Global Oncology Injection Drug Sales 2015-2026
2.2 Oncology Injection Drug Market Size by Region: 2020 Versus 2026
2.2.1 Global Oncology Injection Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Oncology Injection Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL ONCOLOGY INJECTION DRUG COMPETITOR LANDSCAPE BY PLAYERS
3.1 Oncology Injection Drug Sales by Manufacturers
3.1.1 Oncology Injection Drug Sales by Manufacturers (2015-2020)
3.1.2 Oncology Injection Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Oncology Injection Drug Revenue by Manufacturers
3.2.1 Oncology Injection Drug Revenue by Manufacturers (2015-2020)
3.2.2 Oncology Injection Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Oncology Injection Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Oncology Injection Drug Revenue in 2019
3.2.5 Global Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Oncology Injection Drug Price by Manufacturers
3.4 Oncology Injection Drug Manufacturing Base Distribution, Product Types
3.4.1 Oncology Injection Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oncology Injection Drug Product Type
3.4.3 Date of International Manufacturers Enter into Oncology Injection Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Oncology Injection Drug Market Size by Type (2015-2020)
4.1.1 Global Oncology Injection Drug Sales by Type (2015-2020)
4.1.2 Global Oncology Injection Drug Revenue by Type (2015-2020)
4.1.3 Oncology Injection Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Oncology Injection Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Oncology Injection Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Oncology Injection Drug Revenue Forecast by Type (2021-2026)
4.2.3 Oncology Injection Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Oncology Injection Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Oncology Injection Drug Market Size by Application (2015-2020)
5.1.1 Global Oncology Injection Drug Sales by Application (2015-2020)
5.1.2 Global Oncology Injection Drug Revenue by Application (2015-2020)
5.1.3 Oncology Injection Drug Price by Application (2015-2020)
5.2 Oncology Injection Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Oncology Injection Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Oncology Injection Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Oncology Injection Drug Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Oncology Injection Drug by Country
6.1.1 North America Oncology Injection Drug Sales by Country
6.1.2 North America Oncology Injection Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Oncology Injection Drug Market Facts & Figures by Type
6.3 North America Oncology Injection Drug Market Facts & Figures by Application
7 EUROPE
7.1 Europe Oncology Injection Drug by Country
7.1.1 Europe Oncology Injection Drug Sales by Country
7.1.2 Europe Oncology Injection Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oncology Injection Drug Market Facts & Figures by Type
7.3 Europe Oncology Injection Drug Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Oncology Injection Drug by Region
8.1.1 Asia Pacific Oncology Injection Drug Sales by Region
8.1.2 Asia Pacific Oncology Injection Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Oncology Injection Drug Market Facts & Figures by Type
8.3 Asia Pacific Oncology Injection Drug Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Oncology Injection Drug by Country
9.1.1 Latin America Oncology Injection Drug Sales by Country
9.1.2 Latin America Oncology Injection Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Oncology Injection Drug Market Facts & Figures by Type
9.3 Central & South America Oncology Injection Drug Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Oncology Injection Drug by Country
10.1.1 Middle East and Africa Oncology Injection Drug Sales by Country
10.1.2 Middle East and Africa Oncology Injection Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Oncology Injection Drug Market Facts & Figures by Type
10.3 Middle East and Africa Oncology Injection Drug Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Taj Oncology
11.1.1 Taj Oncology Corporation Information
11.1.2 Taj Oncology Description, Business Overview and Total Revenue
11.1.3 Taj Oncology Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Taj Oncology Oncology Injection Drug Products Offered
11.1.5 Taj Oncology Recent Development
11.2 S.G. Biopharm
11.2.1 S.G. Biopharm Corporation Information
11.2.2 S.G. Biopharm Description, Business Overview and Total Revenue
11.2.3 S.G. Biopharm Sales, Revenue and Gross Margin (2015-2020)
11.2.4 S.G. Biopharm Oncology Injection Drug Products Offered
11.2.5 S.G. Biopharm Recent Development
11.3 AdvaCare
11.3.1 AdvaCare Corporation Information
11.3.2 AdvaCare Description, Business Overview and Total Revenue
11.3.3 AdvaCare Sales, Revenue and Gross Margin (2015-2020)
11.3.4 AdvaCare Oncology Injection Drug Products Offered
11.3.5 AdvaCare Recent Development
11.4 Merrimack
11.4.1 Merrimack Corporation Information
11.4.2 Merrimack Description, Business Overview and Total Revenue
11.4.3 Merrimack Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merrimack Oncology Injection Drug Products Offered
11.4.5 Merrimack Recent Development
11.5 Celgene
11.5.1 Celgene Corporation Information
11.5.2 Celgene Description, Business Overview and Total Revenue
11.5.3 Celgene Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Celgene Oncology Injection Drug Products Offered
11.5.5 Celgene Recent Development
11.6 Allos Therapeutics
11.6.1 Allos Therapeutics Corporation Information
11.6.2 Allos Therapeutics Description, Business Overview and Total Revenue
11.6.3 Allos Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Allos Therapeutics Oncology Injection Drug Products Offered
11.6.5 Allos Therapeutics Recent Development
11.7 Ferring Pharmaceuticals
11.7.1 Ferring Pharmaceuticals Corporation Information
11.7.2 Ferring Pharmaceuticals Description, Business Overview and Total Revenue
11.7.3 Ferring Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Ferring Pharmaceuticals Oncology Injection Drug Products Offered
11.7.5 Ferring Pharmaceuticals Recent Development
11.8 Genzyme
11.8.1 Genzyme Corporation Information
11.8.2 Genzyme Description, Business Overview and Total Revenue
11.8.3 Genzyme Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Genzyme Oncology Injection Drug Products Offered
11.8.5 Genzyme Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Corporation Information
11.9.2 Eli Lilly Description, Business Overview and Total Revenue
11.9.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Eli Lilly Oncology Injection Drug Products Offered
11.9.5 Eli Lilly Recent Development
11.10 Praecis Pharmaceuticals
11.10.1 Praecis Pharmaceuticals Corporation Information
11.10.2 Praecis Pharmaceuticals Description, Business Overview and Total Revenue
11.10.3 Praecis Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Praecis Pharmaceuticals Oncology Injection Drug Products Offered
11.10.5 Praecis Pharmaceuticals Recent Development
11.1 Taj Oncology
11.1.1 Taj Oncology Corporation Information
11.1.2 Taj Oncology Description, Business Overview and Total Revenue
11.1.3 Taj Oncology Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Taj Oncology Oncology Injection Drug Products Offered
11.1.5 Taj Oncology Recent Development
11.12 Debiopharm
11.12.1 Debiopharm Corporation Information
11.12.2 Debiopharm Description, Business Overview and Total Revenue
11.12.3 Debiopharm Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Debiopharm Products Offered
11.12.5 Debiopharm Recent Development
11.13 Alza
11.13.1 Alza Corporation Information
11.13.2 Alza Description, Business Overview and Total Revenue
11.13.3 Alza Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Alza Products Offered
11.13.5 Alza Recent Development
11.14 CordenPharma
11.14.1 CordenPharma Corporation Information
11.14.2 CordenPharma Description, Business Overview and Total Revenue
11.14.3 CordenPharma Sales, Revenue and Gross Margin (2015-2020)
11.14.4 CordenPharma Products Offered
11.14.5 CordenPharma Recent Development
11.15 Pharmascience
11.15.1 Pharmascience Corporation Information
11.15.2 Pharmascience Description, Business Overview and Total Revenue
11.15.3 Pharmascience Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Pharmascience Products Offered
11.15.5 Pharmascience Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Oncology Injection Drug Market Estimates and Projections by Region
12.1.1 Global Oncology Injection Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Oncology Injection Drug Revenue Forecast by Regions 2021-2026
12.2 North America Oncology Injection Drug Market Size Forecast (2021-2026)
12.2.1 North America: Oncology Injection Drug Sales Forecast (2021-2026)
12.2.2 North America: Oncology Injection Drug Revenue Forecast (2021-2026)
12.2.3 North America: Oncology Injection Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Oncology Injection Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Oncology Injection Drug Sales Forecast (2021-2026)
12.3.2 Europe: Oncology Injection Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Oncology Injection Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Oncology Injection Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Oncology Injection Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Oncology Injection Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Oncology Injection Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Oncology Injection Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Oncology Injection Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Oncology Injection Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Oncology Injection Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Oncology Injection Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Oncology Injection Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Oncology Injection Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Oncology Injection Drug Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Oncology Injection Drug Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Oncology Injection Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Oncology Injection Drug Market Segments
Table 2. Ranking of Global Top Oncology Injection Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Oncology Injection Drug Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Organs
Table 5. Major Manufacturers of Central Nervous System
Table 6. Major Manufacturers of Circulatory/Musculoskeletal System
Table 7. Major Manufacturers of Other
Table 8. COVID-19 Impact Global Market: (Four Oncology Injection Drug Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Oncology Injection Drug Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Oncology Injection Drug Players to Combat Covid-19 Impact
Table 13. Global Oncology Injection Drug Market Size Growth Rate by Application 2020-2026 (MT)
Table 14. Global Oncology Injection Drug Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 15. Global Oncology Injection Drug Sales by Regions 2015-2020 (MT)
Table 16. Global Oncology Injection Drug Sales Market Share by Regions (2015-2020)
Table 17. Global Oncology Injection Drug Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Oncology Injection Drug Sales by Manufacturers (2015-2020) (MT)
Table 19. Global Oncology Injection Drug Sales Share by Manufacturers (2015-2020)
Table 20. Global Oncology Injection Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Oncology Injection Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Injection Drug as of 2019)
Table 22. Oncology Injection Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Oncology Injection Drug Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Oncology Injection Drug Price (2015-2020) (USD/MT)
Table 25. Oncology Injection Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Oncology Injection Drug Product Type
Table 27. Date of International Manufacturers Enter into Oncology Injection Drug Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Oncology Injection Drug Sales by Type (2015-2020) (MT)
Table 30. Global Oncology Injection Drug Sales Share by Type (2015-2020)
Table 31. Global Oncology Injection Drug Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Oncology Injection Drug Revenue Share by Type (2015-2020)
Table 33. Oncology Injection Drug Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 34. Global Oncology Injection Drug Sales by Application (2015-2020) (MT)
Table 35. Global Oncology Injection Drug Sales Share by Application (2015-2020)
Table 36. North America Oncology Injection Drug Sales by Country (2015-2020) (MT)
Table 37. North America Oncology Injection Drug Sales Market Share by Country (2015-2020)
Table 38. North America Oncology Injection Drug Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Oncology Injection Drug Revenue Market Share by Country (2015-2020)
Table 40. North America Oncology Injection Drug Sales by Type (2015-2020) (MT)
Table 41. North America Oncology Injection Drug Sales Market Share by Type (2015-2020)
Table 42. North America Oncology Injection Drug Sales by Application (2015-2020) (MT)
Table 43. North America Oncology Injection Drug Sales Market Share by Application (2015-2020)
Table 44. Europe Oncology Injection Drug Sales by Country (2015-2020) (MT)
Table 45. Europe Oncology Injection Drug Sales Market Share by Country (2015-2020)
Table 46. Europe Oncology Injection Drug Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Oncology Injection Drug Revenue Market Share by Country (2015-2020)
Table 48. Europe Oncology Injection Drug Sales by Type (2015-2020) (MT)
Table 49. Europe Oncology Injection Drug Sales Market Share by Type (2015-2020)
Table 50. Europe Oncology Injection Drug Sales by Application (2015-2020) (MT)
Table 51. Europe Oncology Injection Drug Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Oncology Injection Drug Sales by Region (2015-2020) (MT)
Table 53. Asia Pacific Oncology Injection Drug Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Oncology Injection Drug Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Oncology Injection Drug Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Oncology Injection Drug Sales by Type (2015-2020) (MT)
Table 57. Asia Pacific Oncology Injection Drug Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Oncology Injection Drug Sales by Application (2015-2020) (MT)
Table 59. Asia Pacific Oncology Injection Drug Sales Market Share by Application (2015-2020)
Table 60. Latin America Oncology Injection Drug Sales by Country (2015-2020) (MT)
Table 61. Latin America Oncology Injection Drug Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Oncology Injection Drug Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Oncology Injection Drug Revenue Market Share by Country (2015-2020)
Table 64. Latin America Oncology Injection Drug Sales by Type (2015-2020) (MT)
Table 65. Latin America Oncology Injection Drug Sales Market Share by Type (2015-2020)
Table 66. Latin America Oncology Injection Drug Sales by Application (2015-2020) (MT)
Table 67. Latin America Oncology Injection Drug Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Oncology Injection Drug Sales by Country (2015-2020) (MT)
Table 69. Middle East and Africa Oncology Injection Drug Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Oncology Injection Drug Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Oncology Injection Drug Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Oncology Injection Drug Sales by Type (2015-2020) (MT)
Table 73. Middle East and Africa Oncology Injection Drug Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Oncology Injection Drug Sales by Application (2015-2020) (MT)
Table 75. Middle East and Africa Oncology Injection Drug Sales Market Share by Application (2015-2020)
Table 76. Taj Oncology Corporation Information
Table 77. Taj Oncology Description and Major Businesses
Table 78. Taj Oncology Oncology Injection Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Taj Oncology Product
Table 80. Taj Oncology Recent Development
Table 81. S.G. Biopharm Corporation Information
Table 82. S.G. Biopharm Description and Major Businesses
Table 83. S.G. Biopharm Oncology Injection Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. S.G. Biopharm Product
Table 85. S.G. Biopharm Recent Development
Table 86. AdvaCare Corporation Information
Table 87. AdvaCare Description and Major Businesses
Table 88. AdvaCare Oncology Injection Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. AdvaCare Product
Table 90. AdvaCare Recent Development
Table 91. Merrimack Corporation Information
Table 92. Merrimack Description and Major Businesses
Table 93. Merrimack Oncology Injection Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Merrimack Product
Table 95. Merrimack Recent Development
Table 96. Celgene Corporation Information
Table 97. Celgene Description and Major Businesses
Table 98. Celgene Oncology Injection Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Celgene Product
Table 100. Celgene Recent Development
Table 101. Allos Therapeutics Corporation Information
Table 102. Allos Therapeutics Description and Major Businesses
Table 103. Allos Therapeutics Oncology Injection Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Allos Therapeutics Product
Table 105. Allos Therapeutics Recent Development
Table 106. Ferring Pharmaceuticals Corporation Information
Table 107. Ferring Pharmaceuticals Description and Major Businesses
Table 108. Ferring Pharmaceuticals Oncology Injection Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Ferring Pharmaceuticals Product
Table 110. Ferring Pharmaceuticals Recent Development
Table 111. Genzyme Corporation Information
Table 112. Genzyme Description and Major Businesses
Table 113. Genzyme Oncology Injection Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. Genzyme Product
Table 115. Genzyme Recent Development
Table 116. Eli Lilly Corporation Information
Table 117. Eli Lilly Description and Major Businesses
Table 118. Eli Lilly Oncology Injection Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. Eli Lilly Product
Table 120. Eli Lilly Recent Development
Table 121. Praecis Pharmaceuticals Corporation Information
Table 122. Praecis Pharmaceuticals Description and Major Businesses
Table 123. Praecis Pharmaceuticals Oncology Injection Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 124. Praecis Pharmaceuticals Product
Table 125. Praecis Pharmaceuticals Recent Development
Table 126. Millennium Pharmaceuticals Corporation Information
Table 127. Millennium Pharmaceuticals Description and Major Businesses
Table 128. Millennium Pharmaceuticals Oncology Injection Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 129. Millennium Pharmaceuticals Product
Table 130. Millennium Pharmaceuticals Recent Development
Table 131. Debiopharm Corporation Information
Table 132. Debiopharm Description and Major Businesses
Table 133. Debiopharm Oncology Injection Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 134. Debiopharm Product
Table 135. Debiopharm Recent Development
Table 136. Alza Corporation Information
Table 137. Alza Description and Major Businesses
Table 138. Alza Oncology Injection Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 139. Alza Product
Table 140. Alza Recent Development
Table 141. CordenPharma Corporation Information
Table 142. CordenPharma Description and Major Businesses
Table 143. CordenPharma Oncology Injection Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 144. CordenPharma Product
Table 145. CordenPharma Recent Development
Table 146. Pharmascience Corporation Information
Table 147. Pharmascience Description and Major Businesses
Table 148. Pharmascience Oncology Injection Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 149. Pharmascience Product
Table 150. Pharmascience Recent Development
Table 151. Global Oncology Injection Drug Sales Forecast by Regions (2021-2026) (MT)
Table 152. Global Oncology Injection Drug Sales Market Share Forecast by Regions (2021-2026)
Table 153. Global Oncology Injection Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 154. Global Oncology Injection Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 155. North America: Oncology Injection Drug Sales Forecast by Country (2021-2026) (MT)
Table 156. North America: Oncology Injection Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 157. Europe: Oncology Injection Drug Sales Forecast by Country (2021-2026) (MT)
Table 158. Europe: Oncology Injection Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 159. Asia Pacific: Oncology Injection Drug Sales Forecast by Region (2021-2026) (MT)
Table 160. Asia Pacific: Oncology Injection Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 161. Latin America: Oncology Injection Drug Sales Forecast by Country (2021-2026) (MT)
Table 162. Latin America: Oncology Injection Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 163. Middle East and Africa: Oncology Injection Drug Sales Forecast by Country (2021-2026) (MT)
Table 164. Middle East and Africa: Oncology Injection Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 165. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 166. Key Challenges
Table 167. Market Risks
Table 168. Main Points Interviewed from Key Oncology Injection Drug Players
Table 169. Oncology Injection Drug Customers List
Table 170. Oncology Injection Drug Distributors List
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
Table 1. Oncology Injection Drug Market Segments
Table 2. Ranking of Global Top Oncology Injection Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Oncology Injection Drug Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Organs
Table 5. Major Manufacturers of Central Nervous System
Table 6. Major Manufacturers of Circulatory/Musculoskeletal System
Table 7. Major Manufacturers of Other
Table 8. COVID-19 Impact Global Market: (Four Oncology Injection Drug Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Oncology Injection Drug Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Oncology Injection Drug Players to Combat Covid-19 Impact
Table 13. Global Oncology Injection Drug Market Size Growth Rate by Application 2020-2026 (MT)
Table 14. Global Oncology Injection Drug Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 15. Global Oncology Injection Drug Sales by Regions 2015-2020 (MT)
Table 16. Global Oncology Injection Drug Sales Market Share by Regions (2015-2020)
Table 17. Global Oncology Injection Drug Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Oncology Injection Drug Sales by Manufacturers (2015-2020) (MT)
Table 19. Global Oncology Injection Drug Sales Share by Manufacturers (2015-2020)
Table 20. Global Oncology Injection Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Oncology Injection Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Injection Drug as of 2019)
Table 22. Oncology Injection Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Oncology Injection Drug Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Oncology Injection Drug Price (2015-2020) (USD/MT)
Table 25. Oncology Injection Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Oncology Injection Drug Product Type
Table 27. Date of International Manufacturers Enter into Oncology Injection Drug Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Oncology Injection Drug Sales by Type (2015-2020) (MT)
Table 30. Global Oncology Injection Drug Sales Share by Type (2015-2020)
Table 31. Global Oncology Injection Drug Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Oncology Injection Drug Revenue Share by Type (2015-2020)
Table 33. Oncology Injection Drug Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 34. Global Oncology Injection Drug Sales by Application (2015-2020) (MT)
Table 35. Global Oncology Injection Drug Sales Share by Application (2015-2020)
Table 36. North America Oncology Injection Drug Sales by Country (2015-2020) (MT)
Table 37. North America Oncology Injection Drug Sales Market Share by Country (2015-2020)
Table 38. North America Oncology Injection Drug Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Oncology Injection Drug Revenue Market Share by Country (2015-2020)
Table 40. North America Oncology Injection Drug Sales by Type (2015-2020) (MT)
Table 41. North America Oncology Injection Drug Sales Market Share by Type (2015-2020)
Table 42. North America Oncology Injection Drug Sales by Application (2015-2020) (MT)
Table 43. North America Oncology Injection Drug Sales Market Share by Application (2015-2020)
Table 44. Europe Oncology Injection Drug Sales by Country (2015-2020) (MT)
Table 45. Europe Oncology Injection Drug Sales Market Share by Country (2015-2020)
Table 46. Europe Oncology Injection Drug Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Oncology Injection Drug Revenue Market Share by Country (2015-2020)
Table 48. Europe Oncology Injection Drug Sales by Type (2015-2020) (MT)
Table 49. Europe Oncology Injection Drug Sales Market Share by Type (2015-2020)
Table 50. Europe Oncology Injection Drug Sales by Application (2015-2020) (MT)
Table 51. Europe Oncology Injection Drug Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Oncology Injection Drug Sales by Region (2015-2020) (MT)
Table 53. Asia Pacific Oncology Injection Drug Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Oncology Injection Drug Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Oncology Injection Drug Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Oncology Injection Drug Sales by Type (2015-2020) (MT)
Table 57. Asia Pacific Oncology Injection Drug Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Oncology Injection Drug Sales by Application (2015-2020) (MT)
Table 59. Asia Pacific Oncology Injection Drug Sales Market Share by Application (2015-2020)
Table 60. Latin America Oncology Injection Drug Sales by Country (2015-2020) (MT)
Table 61. Latin America Oncology Injection Drug Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Oncology Injection Drug Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Oncology Injection Drug Revenue Market Share by Country (2015-2020)
Table 64. Latin America Oncology Injection Drug Sales by Type (2015-2020) (MT)
Table 65. Latin America Oncology Injection Drug Sales Market Share by Type (2015-2020)
Table 66. Latin America Oncology Injection Drug Sales by Application (2015-2020) (MT)
Table 67. Latin America Oncology Injection Drug Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Oncology Injection Drug Sales by Country (2015-2020) (MT)
Table 69. Middle East and Africa Oncology Injection Drug Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Oncology Injection Drug Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Oncology Injection Drug Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Oncology Injection Drug Sales by Type (2015-2020) (MT)
Table 73. Middle East and Africa Oncology Injection Drug Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Oncology Injection Drug Sales by Application (2015-2020) (MT)
Table 75. Middle East and Africa Oncology Injection Drug Sales Market Share by Application (2015-2020)
Table 76. Taj Oncology Corporation Information
Table 77. Taj Oncology Description and Major Businesses
Table 78. Taj Oncology Oncology Injection Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Taj Oncology Product
Table 80. Taj Oncology Recent Development
Table 81. S.G. Biopharm Corporation Information
Table 82. S.G. Biopharm Description and Major Businesses
Table 83. S.G. Biopharm Oncology Injection Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. S.G. Biopharm Product
Table 85. S.G. Biopharm Recent Development
Table 86. AdvaCare Corporation Information
Table 87. AdvaCare Description and Major Businesses
Table 88. AdvaCare Oncology Injection Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. AdvaCare Product
Table 90. AdvaCare Recent Development
Table 91. Merrimack Corporation Information
Table 92. Merrimack Description and Major Businesses
Table 93. Merrimack Oncology Injection Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Merrimack Product
Table 95. Merrimack Recent Development
Table 96. Celgene Corporation Information
Table 97. Celgene Description and Major Businesses
Table 98. Celgene Oncology Injection Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Celgene Product
Table 100. Celgene Recent Development
Table 101. Allos Therapeutics Corporation Information
Table 102. Allos Therapeutics Description and Major Businesses
Table 103. Allos Therapeutics Oncology Injection Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Allos Therapeutics Product
Table 105. Allos Therapeutics Recent Development
Table 106. Ferring Pharmaceuticals Corporation Information
Table 107. Ferring Pharmaceuticals Description and Major Businesses
Table 108. Ferring Pharmaceuticals Oncology Injection Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Ferring Pharmaceuticals Product
Table 110. Ferring Pharmaceuticals Recent Development
Table 111. Genzyme Corporation Information
Table 112. Genzyme Description and Major Businesses
Table 113. Genzyme Oncology Injection Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. Genzyme Product
Table 115. Genzyme Recent Development
Table 116. Eli Lilly Corporation Information
Table 117. Eli Lilly Description and Major Businesses
Table 118. Eli Lilly Oncology Injection Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. Eli Lilly Product
Table 120. Eli Lilly Recent Development
Table 121. Praecis Pharmaceuticals Corporation Information
Table 122. Praecis Pharmaceuticals Description and Major Businesses
Table 123. Praecis Pharmaceuticals Oncology Injection Drug Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 124. Praecis Pharmaceuticals Product
Table 125. Praecis Pharmaceuticals Recent Development
Table 126. Millennium Pharmaceuticals Corporation Information
Table 127. Millennium Pharmaceuticals Description and Major Businesses
Table 128. Millennium Pharmaceuticals Oncology Injection Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 129. Millennium Pharmaceuticals Product
Table 130. Millennium Pharmaceuticals Recent Development
Table 131. Debiopharm Corporation Information
Table 132. Debiopharm Description and Major Businesses
Table 133. Debiopharm Oncology Injection Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 134. Debiopharm Product
Table 135. Debiopharm Recent Development
Table 136. Alza Corporation Information
Table 137. Alza Description and Major Businesses
Table 138. Alza Oncology Injection Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 139. Alza Product
Table 140. Alza Recent Development
Table 141. CordenPharma Corporation Information
Table 142. CordenPharma Description and Major Businesses
Table 143. CordenPharma Oncology Injection Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 144. CordenPharma Product
Table 145. CordenPharma Recent Development
Table 146. Pharmascience Corporation Information
Table 147. Pharmascience Description and Major Businesses
Table 148. Pharmascience Oncology Injection Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 149. Pharmascience Product
Table 150. Pharmascience Recent Development
Table 151. Global Oncology Injection Drug Sales Forecast by Regions (2021-2026) (MT)
Table 152. Global Oncology Injection Drug Sales Market Share Forecast by Regions (2021-2026)
Table 153. Global Oncology Injection Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 154. Global Oncology Injection Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 155. North America: Oncology Injection Drug Sales Forecast by Country (2021-2026) (MT)
Table 156. North America: Oncology Injection Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 157. Europe: Oncology Injection Drug Sales Forecast by Country (2021-2026) (MT)
Table 158. Europe: Oncology Injection Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 159. Asia Pacific: Oncology Injection Drug Sales Forecast by Region (2021-2026) (MT)
Table 160. Asia Pacific: Oncology Injection Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 161. Latin America: Oncology Injection Drug Sales Forecast by Country (2021-2026) (MT)
Table 162. Latin America: Oncology Injection Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 163. Middle East and Africa: Oncology Injection Drug Sales Forecast by Country (2021-2026) (MT)
Table 164. Middle East and Africa: Oncology Injection Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 165. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 166. Key Challenges
Table 167. Market Risks
Table 168. Main Points Interviewed from Key Oncology Injection Drug Players
Table 169. Oncology Injection Drug Customers List
Table 170. Oncology Injection Drug Distributors List
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Oncology Injection Drug Product Picture
Figure 2. Global Oncology Injection Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Organs Product Picture
Figure 4. Central Nervous System Product Picture
Figure 5. Circulatory/Musculoskeletal System Product Picture
Figure 6. Other Product Picture
Figure 7. Global Oncology Injection Drug Sales Market Share by Application in 2020 & 2026
Figure 8. Lymphoma
Figure 9. Myeloma
Figure 10. Prostate Cancer
Figure 11. Other
Figure 12. Oncology Injection Drug Report Years Considered
Figure 13. Global Oncology Injection Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Oncology Injection Drug Sales 2015-2026 (MT)
Figure 15. Global Oncology Injection Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Oncology Injection Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Oncology Injection Drug Sales Market Share by Region in 2019
Figure 18. Global Oncology Injection Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Oncology Injection Drug Revenue Market Share by Region in 2019
Figure 20. Global Oncology Injection Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Oncology Injection Drug Revenue in 2019
Figure 22. Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Oncology Injection Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Oncology Injection Drug Sales Market Share by Type in 2019
Figure 25. Global Oncology Injection Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Oncology Injection Drug Revenue Market Share by Type in 2019
Figure 27. Global Oncology Injection Drug Market Share by Price Range (2015-2020)
Figure 28. Global Oncology Injection Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Oncology Injection Drug Sales Market Share by Application in 2019
Figure 30. Global Oncology Injection Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Oncology Injection Drug Revenue Market Share by Application in 2019
Figure 32. North America Oncology Injection Drug Sales Growth Rate 2015-2020 (MT)
Figure 33. North America Oncology Injection Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Oncology Injection Drug Sales Market Share by Country in 2019
Figure 35. North America Oncology Injection Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 37. U.S. Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 39. Canada Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Oncology Injection Drug Market Share by Type in 2019
Figure 41. North America Oncology Injection Drug Market Share by Application in 2019
Figure 42. Europe Oncology Injection Drug Sales Growth Rate 2015-2020 (MT)
Figure 43. Europe Oncology Injection Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Oncology Injection Drug Sales Market Share by Country in 2019
Figure 45. Europe Oncology Injection Drug Revenue Market Share by Country in 2019
Figure 46. Germany Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 47. Germany Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 49. France Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 51. U.K. Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 53. Italy Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 55. Russia Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Oncology Injection Drug Market Share by Type in 2019
Figure 57. Europe Oncology Injection Drug Market Share by Application in 2019
Figure 58. Asia Pacific Oncology Injection Drug Sales Growth Rate 2015-2020 (MT)
Figure 59. Asia Pacific Oncology Injection Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Oncology Injection Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Oncology Injection Drug Revenue Market Share by Region in 2019
Figure 62. China Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 63. China Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 65. Japan Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 67. South Korea Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 69. India Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 71. Australia Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 73. Taiwan Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 75. Indonesia Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 77. Thailand Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 79. Malaysia Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 81. Philippines Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 83. Vietnam Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Oncology Injection Drug Market Share by Type in 2019
Figure 85. Asia Pacific Oncology Injection Drug Market Share by Application in 2019
Figure 86. Latin America Oncology Injection Drug Sales Growth Rate 2015-2020 (MT)
Figure 87. Latin America Oncology Injection Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Oncology Injection Drug Sales Market Share by Country in 2019
Figure 89. Latin America Oncology Injection Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 91. Mexico Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 93. Brazil Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 95. Argentina Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Oncology Injection Drug Market Share by Type in 2019
Figure 97. Latin America Oncology Injection Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Oncology Injection Drug Sales Growth Rate 2015-2020 (MT)
Figure 99. Middle East and Africa Oncology Injection Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Oncology Injection Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Oncology Injection Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 103. Turkey Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 105. Saudi Arabia Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 107. U.A.E Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Oncology Injection Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Oncology Injection Drug Market Share by Application in 2019
Figure 110. Taj Oncology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. S.G. Biopharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. AdvaCare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Merrimack Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Allos Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Ferring Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Genzyme Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Praecis Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Millennium Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Debiopharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Alza Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. CordenPharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 124. Pharmascience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 125. North America Oncology Injection Drug Sales Growth Rate Forecast (2021-2026) (MT)
Figure 126. North America Oncology Injection Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Europe Oncology Injection Drug Sales Growth Rate Forecast (2021-2026) (MT)
Figure 128. Europe Oncology Injection Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Asia Pacific Oncology Injection Drug Sales Growth Rate Forecast (2021-2026) (MT)
Figure 130. Asia Pacific Oncology Injection Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Latin America Oncology Injection Drug Sales Growth Rate Forecast (2021-2026) (MT)
Figure 132. Latin America Oncology Injection Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 133. Middle East and Africa Oncology Injection Drug Sales Growth Rate Forecast (2021-2026) (MT)
Figure 134. Middle East and Africa Oncology Injection Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 135. Porter's Five Forces Analysis
Figure 136. Channels of Distribution
Figure 137. Distributors Profiles
Figure 138. Bottom-up and Top-down Approaches for This Report
Figure 139. Data Triangulation
Figure 140. Key Executives Interviewed
Figure 1. Oncology Injection Drug Product Picture
Figure 2. Global Oncology Injection Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Organs Product Picture
Figure 4. Central Nervous System Product Picture
Figure 5. Circulatory/Musculoskeletal System Product Picture
Figure 6. Other Product Picture
Figure 7. Global Oncology Injection Drug Sales Market Share by Application in 2020 & 2026
Figure 8. Lymphoma
Figure 9. Myeloma
Figure 10. Prostate Cancer
Figure 11. Other
Figure 12. Oncology Injection Drug Report Years Considered
Figure 13. Global Oncology Injection Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Oncology Injection Drug Sales 2015-2026 (MT)
Figure 15. Global Oncology Injection Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Oncology Injection Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Oncology Injection Drug Sales Market Share by Region in 2019
Figure 18. Global Oncology Injection Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Oncology Injection Drug Revenue Market Share by Region in 2019
Figure 20. Global Oncology Injection Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Oncology Injection Drug Revenue in 2019
Figure 22. Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Oncology Injection Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Oncology Injection Drug Sales Market Share by Type in 2019
Figure 25. Global Oncology Injection Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Oncology Injection Drug Revenue Market Share by Type in 2019
Figure 27. Global Oncology Injection Drug Market Share by Price Range (2015-2020)
Figure 28. Global Oncology Injection Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Oncology Injection Drug Sales Market Share by Application in 2019
Figure 30. Global Oncology Injection Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Oncology Injection Drug Revenue Market Share by Application in 2019
Figure 32. North America Oncology Injection Drug Sales Growth Rate 2015-2020 (MT)
Figure 33. North America Oncology Injection Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Oncology Injection Drug Sales Market Share by Country in 2019
Figure 35. North America Oncology Injection Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 37. U.S. Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 39. Canada Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Oncology Injection Drug Market Share by Type in 2019
Figure 41. North America Oncology Injection Drug Market Share by Application in 2019
Figure 42. Europe Oncology Injection Drug Sales Growth Rate 2015-2020 (MT)
Figure 43. Europe Oncology Injection Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Oncology Injection Drug Sales Market Share by Country in 2019
Figure 45. Europe Oncology Injection Drug Revenue Market Share by Country in 2019
Figure 46. Germany Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 47. Germany Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 49. France Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 51. U.K. Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 53. Italy Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 55. Russia Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Oncology Injection Drug Market Share by Type in 2019
Figure 57. Europe Oncology Injection Drug Market Share by Application in 2019
Figure 58. Asia Pacific Oncology Injection Drug Sales Growth Rate 2015-2020 (MT)
Figure 59. Asia Pacific Oncology Injection Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Oncology Injection Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Oncology Injection Drug Revenue Market Share by Region in 2019
Figure 62. China Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 63. China Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 65. Japan Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 67. South Korea Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 69. India Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 71. Australia Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 73. Taiwan Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 75. Indonesia Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 77. Thailand Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 79. Malaysia Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 81. Philippines Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 83. Vietnam Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Oncology Injection Drug Market Share by Type in 2019
Figure 85. Asia Pacific Oncology Injection Drug Market Share by Application in 2019
Figure 86. Latin America Oncology Injection Drug Sales Growth Rate 2015-2020 (MT)
Figure 87. Latin America Oncology Injection Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Oncology Injection Drug Sales Market Share by Country in 2019
Figure 89. Latin America Oncology Injection Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 91. Mexico Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 93. Brazil Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 95. Argentina Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Oncology Injection Drug Market Share by Type in 2019
Figure 97. Latin America Oncology Injection Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Oncology Injection Drug Sales Growth Rate 2015-2020 (MT)
Figure 99. Middle East and Africa Oncology Injection Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Oncology Injection Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Oncology Injection Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 103. Turkey Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 105. Saudi Arabia Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Oncology Injection Drug Sales Growth Rate (2015-2020) (MT)
Figure 107. U.A.E Oncology Injection Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Oncology Injection Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Oncology Injection Drug Market Share by Application in 2019
Figure 110. Taj Oncology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. S.G. Biopharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. AdvaCare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Merrimack Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Allos Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Ferring Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Genzyme Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Praecis Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Millennium Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Debiopharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Alza Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. CordenPharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 124. Pharmascience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 125. North America Oncology Injection Drug Sales Growth Rate Forecast (2021-2026) (MT)
Figure 126. North America Oncology Injection Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Europe Oncology Injection Drug Sales Growth Rate Forecast (2021-2026) (MT)
Figure 128. Europe Oncology Injection Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Asia Pacific Oncology Injection Drug Sales Growth Rate Forecast (2021-2026) (MT)
Figure 130. Asia Pacific Oncology Injection Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Latin America Oncology Injection Drug Sales Growth Rate Forecast (2021-2026) (MT)
Figure 132. Latin America Oncology Injection Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 133. Middle East and Africa Oncology Injection Drug Sales Growth Rate Forecast (2021-2026) (MT)
Figure 134. Middle East and Africa Oncology Injection Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 135. Porter's Five Forces Analysis
Figure 136. Channels of Distribution
Figure 137. Distributors Profiles
Figure 138. Bottom-up and Top-down Approaches for This Report
Figure 139. Data Triangulation
Figure 140. Key Executives Interviewed
